Gilead Sciences (GILD) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 23.4 | 9.72 | 14.8 | 14.2 | 11.3 | 863.5 | ||
| Changes by years, y/y, % | +118% | -58% | +52% | -4% | -20% | +5.5% | |||
Gilead Sciences. EV/EBITDA
Gilead Sciences. EV/EBITDA, changes, %
Gilead Sciences (GILD) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 10.3 | 25.4 | 19.9 | 10.7 | 42.0 | 863.5 | |
| Changes by years, y/y, % | -20% | +99% | +66% | -7% | +266% | |||
| Changes by quarters, q/q, % | -14% | +148% | -22% | -46% | +293% | |||